China’s First Home Grown Novel HIV Drug Shoots For Prime Time

With a fast-growing HIV population and reliance on older-generation treatments, China could become the next frontier for new antiretroviral drugs. Government support might see the country’s first novel locally developed, long-lasting injectable product take on the big names in the field.

3D virus

A new fusion inhibitor that prevents HIV entry into cells, albuvirtide, has reached its primary endpoint in a Phase III trial conducted in China, opening the way to the possible approval in this market of what would be the country’s first domestically developed original drug for the disease.

"The results show that albuvirtide is equivalent in efficacy to the current second-line treatment recommended by the World Health Organization...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip